Building a new economic evaluation database for the cochrane schizophrenia group: Searching the HEED, NHS EED, CEA registry and economic literature
Mansi, Kamel Furtado, Vivek Adams, Clive E. Roberts, Samantha
Mansi, Kamel
Furtado, Vivek
Adams, Clive E.
Roberts, Samantha
Abstract
The Cochrane Schizophrenia Group formed in 1994 is part of the Cochrane Collaboration and is located at the University of Nottingham. It is also part of the Institute of Mental Health based at Nottingham. The Cochrane Schizophrenia Group is concerned with the evaluation of the prevention, treatment and rehabilitation of people with non-affective, functional, psychotic illnesses. The treatment of those with schizophrenia is a major focus of the Group but it is also concerned with the care of those suffering from unspecified 'chronic/severe' mental illnesses and non-organic, schizophrenialike conditions fall under the Group's umbrella. The CSG work and website focuses on two main areas. The first is the preparation, publication and maintenance of systematic reviews of the effects of interventions for schizophrenia. These reviews are published monthly on The Cochrane Library, and are updated periodically to incorporate new research as it becomes available. The second is the development and maintenance of a specialised register of trials relevant to the scope of the group's work. All reports of Randomised Controlled Trials relevant to the scope of this group, whether randomisation is described or implied, are acquired, coded and included. The Cochrane Schizophrenia Group's Register contains 13593 coded studies (April 2011). The register is maintained on Meerkat 1.6. The Group also maintains a large register of citations (~ 100, 000) and papers (~7767) that have been inspected and found not relevant to the work of this Group. Although, searching covers a vast array of databases, health economic databases are specifically not searched. With a growing interest in systematic reviews of economic evaluations, there was need to see if searching of specialist databases would yield further economic evaluation trials hitherto not found in the CSG Specialised Register. Should it be the case then there would be a need to have a database that included economic evaluations of schizophrenia trials. The health economic evaluation database (HEED), NHS economic evaluation database (NHS EED), the Cost-Effectiveness Analysis (CEA) registry and the economic literature are comprehensive databases of around 9421 cost-effectiveness and utility analyses on a wide variety of schizophrenia antipsychotics. The impact of these databases has led to them being highlighted in the National Library of Medicine's website as an important health economics resource. One of the main goals of these databases will serve as ongoing source of information for those seeking to identify under-studied areas in the cost-effectiveness literature.
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2013
Type
Conference Proceeding
Collections
Citation
Mansi, K., Furtado, V., Adams, C. E. and Roberts, S. (2013). Building a new economic evaluation database for the cochrane schizophrenia group: Searching the HEED, NHS EED, CEA registry and economic literature. In: Moscarelli, M. & French, M., (Eds.) 11th Workshop on Costs and Assessment in Psychiatry, 22-24 March 2013 Venice, Italy. Chichester: Journal of Mental Health Policy and Economics, p.S23.